Solving the protein structure prediction problem by AlphaFold2(AF2) from sequence seems at its core a game-changing breakthrough. Major areas of biology and biophysics will thrive and others may become diminished or even obsolete.
Will AF2 hurt or benefit experimental methods for determination of protein structure? Structures of large macromolecular machines should be enabled by having accurate computational structures for subunits and components. X-ray structure value may become more specialized. One thing that seems likely is that the already great value of sequence data (which is doubling every 8 months) is likely to become far greater by being more directly connected to spatial information. At its core solving the protein folding problem will enhance sequence impact and thereby increase the overall the pace of biology and biophysical advances by improving the ability of structural biology to better harness the flood of sequence data. How much will medical areas such as cancer biology and cancer drug discovery benefit? How about research areas such as protein design? What areas are likely to be most powerfully advanced and which most negatively impacted? What do you think?
How should senior and early stage researchers position themselves to ride the wave of growing positive impacts and reduce research wipeouts when this new mega-wave adds constructively or destructively with current research waves of systems biology and single molecule and single cell advances? What should we change in training for graduate students and fellows to insure they are correctly positioned for science with reliable protein structure prediction?